Thus, it is likely that β2AR desensitization may have antagonized the protective effect of high‐dose formoterol on EPO‐induced AAA, as supported by our finding that gene knockdown of β2AR blocked the suppressive effect of formoterol on VSMC senescence‐induced by EPO. The gene discussed is ADRB2; the disease is triple-A syndrome.